CliffBio
small molecule

EUTHYROX

LEVOTHYROXINE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyEMD Serono →See this company's full patent-cliff portfolio

Drug detail

Brand nameEUTHYROX
Active ingredientLEVOTHYROXINE SODIUM
Strength0.137MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2002
Marketing statusDISCN

More from EMD Serono

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

EUTHYROX patent cliff — loss of exclusivity — | CliffBio